pulmonary disorders
Hepatopulmonary Syndrome
Treatment of Hepatopulmonary Syndrome
Supplemental oxygen The main treatment is supplemental oxygen for symptoms. Other therapies, such as somatostatin to inhibit vasodilation, are of modest benefit in only some patients. Coil embolization is virtually impossible because of the number and size of the lesions. Inhaled nitric oxide synthesis inhibitors may be a future treatment option. Hepatopulmonary syndrome may regress after Liver Transplantation or if the underlying liver disease subsides. Prognosis is poor without treatment (survival 